Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
Medicina (Kaunas) ; 57(9)2021 Aug 27.
Article in English | MEDLINE | ID: mdl-34577805

ABSTRACT

We present a case of an immunocompromised systemic lupus erythematosus female patient admitted to our hospital for general impairment, monoparesis, and temporary cognitive disability. The case represented a significant diagnostic and therapeutic challenge primarily because of a wide range of differential diagnosis options (CNS lupus, ischemic cerebrovascular disease, viral meningoencephalitis, progressive multifocal leukoencephalopathy, limbic encephalitis, and acute disseminated encephalomyelitis-ADEM). Brain MRI findings were compatible with ADEM, and microbiological tests showed a cytomegalovirus infection (CMV) which is rarely associated with ADEM despite the increasing number of immunocompromised patients prone to symptomatic CMV reactivation. Our patient was treated with intravenous methylprednisolone, immunoglobulin (IVIG), along with antiviral therapy resulting in a favorable therapeutic effect. In conclusion, only a few described ADEM cases have been associated with CMV, and none of them, to the best of our knowledge, in an immunocompromised patient. In this case, a multidisciplinary approach and broad diagnostic considerations were decisive for successful treatment and outcome.


Subject(s)
Cytomegalovirus Infections , Encephalomyelitis, Acute Disseminated , Lupus Erythematosus, Systemic , Cytomegalovirus , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/drug therapy , Encephalomyelitis, Acute Disseminated/diagnosis , Encephalomyelitis, Acute Disseminated/drug therapy , Encephalomyelitis, Acute Disseminated/etiology , Female , Humans , Immunocompromised Host , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/drug therapy , Magnetic Resonance Imaging
3.
Clin Nucl Med ; 39(6): 556-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24662646

ABSTRACT

Dual ectopic lingual and sublingual thyroid gland is an extraordinarily rare condition. We present 1 patient with subclinical hypothyroidism. The clinical examination revealed that the thyroid gland was not palpable in its usual cervical location, whereas ultrasonography confirmed an empty thyroid bed without any ectopic thyroid tissue in the rest of the neck. The final diagnosis of dual ectopic lingual and sublingual thyroid was established by ultrasound examination through the mouth floor and confirmed by scintigraphy and CT thereafter.


Subject(s)
Choristoma/diagnostic imaging , Lingual Thyroid/diagnostic imaging , Thyroid Gland/abnormalities , Thyroid Gland/diagnostic imaging , Female , Humans , Middle Aged , Radionuclide Imaging , Sodium Pertechnetate Tc 99m , Tomography, X-Ray Computed , Ultrasonography
4.
Croat Med J ; 52(1): 41-7, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21328719

ABSTRACT

AIM: To compare the blood lactate levels between patients with psychotic disorder receiving first- and those receiving second-generation antipsychotics. METHODS: The study was conducted at the psychiatric inpatient and outpatient clinics of the Split Clinical Hospital from June 6, 2008 to October 10, 2009. Sixty patients with psychotic disorder who were assigned to 6-month treatment were divided in two groups: 30 received haloperidol (first generation antipsychotic) and 30 received olanzapine (second generation antipsychotic). Blood lactate levels, other metabolic parameters, and scores on the extrapyramidal symptom rating scale were assessed. RESULTS: Patients receiving haloperidol had significantly higher blood lactate levels than patients receiving olanzapine (P < 0.001). They also more frequently had parkinsonism, which was significantly correlated with both haloperidol treatment at 1 month (P < 0.001) and 6 months (P = 0.016) and olanzapine treatment at baseline (P = 0.016), 3 months (P = 0.019), and 6 months (P = 0.021). Also, patients receiving haloperidol had significant correlation between blood lactate and dystonia at 1 month (P < 0.001) and 6 months (P = 0.012) and tardive dyskinesia at 1 month (P = 0.032). There was a significant difference between the treatment groups in lactate levels at all points from baseline to month 6 (P < 0.001). CONCLUSION: It is important to be aware of the potential effect of haloperidol treatment on increase in blood lactate levels and occurrence of extrapyramidal side effects. Therefore, alternative antipsychotics should be prescribed with lower risk of adverse side effects.


Subject(s)
Benzodiazepines , Haloperidol , Lactic Acid/metabolism , Movement Disorders/metabolism , Parkinson Disease, Secondary/metabolism , Psychotic Disorders , Adult , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/agonists , Benzodiazepines/administration & dosage , Benzodiazepines/adverse effects , Dopamine Antagonists/administration & dosage , Dopamine Antagonists/adverse effects , Drug Monitoring , Haloperidol/administration & dosage , Haloperidol/adverse effects , Humans , Male , Middle Aged , Movement Disorders/diagnosis , Movement Disorders/etiology , Olanzapine , Parkinson Disease, Secondary/chemically induced , Parkinson Disease, Secondary/diagnosis , Psychiatric Status Rating Scales , Psychotic Disorders/complications , Psychotic Disorders/drug therapy , Psychotic Disorders/metabolism , Psychotic Disorders/physiopathology , Selective Serotonin Reuptake Inhibitors/administration & dosage , Selective Serotonin Reuptake Inhibitors/adverse effects , Treatment Outcome
5.
Int J Radiat Oncol Biol Phys ; 73(5): 1313-8, 2009 Apr 01.
Article in English | MEDLINE | ID: mdl-18963541

ABSTRACT

PURPOSE: To assess whether pretreatment perfusion computed tomography (PCT) may predict outcome in chemoradiated patients with oral cavity, oropharynx, and hypopharynx squamous cell carcinoma (SCCA) after surgical excision. MATERIALS AND METHODS: Twenty-one patients with SCCA were examined before treatment. The primary site was oral cavity in 6, oropharynx in 7, and hypopharynx in 8 patients; there were 11 T2, 6 T3, and 4 T4 tumors. PCT was performed at the level of largest tumor diameter based on standard neck CT. The data were processed to obtain blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability surface area product (PS). Regions of interest were free-hand positioned on the lesions to obtain PCT measurements. Tumor volume was also calculated. Follow-up was performed with positron emission tomography (PET)/CT and endoscopy. Pearson correlation coefficient was used for comparison between the subgroups. A regression model was constructed to predict recurrence based on the following predictors: age, gender, tumor (T) and nodal (N) stage, tumor volume, and PCT parameters. RESULTS: BF(mean), BF(max), BV(mean), BV(max), MTT(mean), PS(mean), and PS(max) were significantly different between patients with and without tumor recurrence (0.0001, p < 0.04). T stage, tumor volume, N stage, BF(max), BV(max), MTT(mean), and radiation dose (p < 0.001) were independent predictors for recurrence. Cox proportional hazards model for tumor recurrence revealed significantly increased risk with high tumor volume (p = 0.00001, relative risk [RR] 7.4), low PS(mean) (p = 0.0001, RR 14.3), and low BF(max) (p = 0.002, RR 5.9). CONCLUSIONS: Our data suggest that PCT parameters have a prognostic role in patients with SCCA.


Subject(s)
Carcinoma, Squamous Cell/therapy , Hypopharyngeal Neoplasms/therapy , Mouth Neoplasms/therapy , Oropharyngeal Neoplasms/therapy , Adult , Aged , Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/blood supply , Carcinoma, Squamous Cell/pathology , Combined Modality Therapy/methods , Female , Humans , Hypopharyngeal Neoplasms/blood supply , Hypopharyngeal Neoplasms/pathology , Male , Microcirculation , Middle Aged , Mouth Neoplasms/blood supply , Mouth Neoplasms/pathology , Neoplasm Recurrence, Local , Odds Ratio , Oropharyngeal Neoplasms/blood supply , Oropharyngeal Neoplasms/pathology , Positron-Emission Tomography/methods , Prognosis , Prospective Studies , Radiotherapy Dosage , Tomography, X-Ray Computed/methods , Treatment Outcome , Tumor Burden
SELECTION OF CITATIONS
SEARCH DETAIL
...